Dimitrios Karussis

Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis

Dimitrios Karussis, Clementine Karageorgiou, Adi Vaknin‐Dembinsky et al. · Archives of Neurology · 2010 · 952 citations · Full text

Life Sciences, Immunology, Neurology +17

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Neuroprotection and Immunomodulation With Mesenchymal Stem Cells in Chronic Experimental Autoimmune Encephalomyelitis

Ibrahim Kassis, Nikolaos Grigoriadis, Basan Gowda-Kurkalli et al. · Archives of Neurology · 2008 · 338 citations

Life Sciences, Neurology, Neuroscience +15

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis

Panayiota Petrou, Yaël Gothelf, Zohar Argov et al. · JAMA Neurology · 2016 · 302 citations · Full text

Medicine, Neurology, Neuroscience +15